Literature DB >> 25404030

IL12Rβ1ΔTM is a secreted product of il12rb1 that promotes control of extrapulmonary tuberculosis.

Aurelie A Ray1, Jeffrey J Fountain1, Halli E Miller2, Andrea M Cooper1, Richard T Robinson3.   

Abstract

IL12RB1 is a human gene that is important for resistance to Mycobacterium tuberculosis infection. IL12RB1 is expressed by multiple leukocyte lineages, and encodes a type I transmembrane protein (IL12Rβ1) that associates with IL12p40 and promotes the development of host-protective T(H)1 cells. Recently, we observed that il12rb1—the mouse homolog of IL12RB1—is alternatively spliced by leukocytes to produce a second isoform (IL12Rβ1ΔTM) that has biological properties distinct from IL12Rβ1. Although the expression of IL12Rβ1ΔTM is elicited by M. tuberculosis in vivo, and its overexpression enhances IL12p40 responsiveness in vitro, the contribution of IL12Rβ1ΔTM to controlling M. tuberculosis infection has not been tested. Here, we demonstrate that IL12Rβ1ΔTM represents a secreted product of il12rb1 that, when absent from mice, compromises their ability to control M. tuberculosis infection in extrapulmonary organs. Furthermore, elevated M. tuberculosis burdens in IL12Rβ1ΔTM-deficient animals are associated with decreased lymph node cellularity and a decline in TH1 development. Collectively, these data support a model wherein IL12Rβ1ΔTM is a secreted product of il12rb1 that promotes resistance to M. tuberculosis infection by potentiating T(H) cells response to IL-12.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25404030      PMCID: PMC4294230          DOI: 10.1128/IAI.01230-13

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  73 in total

Review 1.  Mechanisms of alternative pre-messenger RNA splicing.

Authors:  Douglas L Black
Journal:  Annu Rev Biochem       Date:  2003-02-27       Impact factor: 23.643

Review 2.  Mechanisms of soluble cytokine receptor generation.

Authors:  Stewart J Levine
Journal:  J Immunol       Date:  2004-11-01       Impact factor: 5.422

Review 3.  Genetic variations in the interleukin-12/interleukin-23 receptor (beta1) chain, and implications for IL-12 and IL-23 receptor structure and function.

Authors:  Esther van de Vosse; Elgin G R Lichtenauer-Kaligis; Jaap T van Dissel; Tom H M Ottenhoff
Journal:  Immunogenetics       Date:  2003-02-21       Impact factor: 2.846

4.  Targeted oncogene activation by site-specific recombination in transgenic mice.

Authors:  M Lakso; B Sauer; B Mosinger; E J Lee; R W Manning; S H Yu; K L Mulder; H Westphal
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

5.  The murine interleukin-4 receptor: molecular cloning and characterization of secreted and membrane bound forms.

Authors:  B Mosley; M P Beckmann; C J March; R L Idzerda; S D Gimpel; T VandenBos; D Friend; A Alpert; D Anderson; J Jackson
Journal:  Cell       Date:  1989-10-20       Impact factor: 41.582

6.  Severe Mycobacterium bovis BCG infections in a large series of novel IL-12 receptor beta1 deficient patients and evidence for the existence of partial IL-12 receptor beta1 deficiency.

Authors:  Elgin G R Lichtenauer-Kaligis; Tjitske de Boer; Frank A W Verreck; Sjaak van Voorden; Marieke A Hoeve; Esther van de Vosse; Fugen Ersoy; Ilhan Tezcan; Jaap T van Dissel; Ozden Sanal; Tom H M Ottenhoff
Journal:  Eur J Immunol       Date:  2003-01       Impact factor: 5.532

7.  Identification and characterization of a novel spliced variant that encodes human soluble tumor necrosis factor receptor 2.

Authors:  Begoña Lainez; José Manuel Fernandez-Real; Xavier Romero; Enric Esplugues; Juan D Cañete; Wifredo Ricart; Pablo Engel
Journal:  Int Immunol       Date:  2004-01       Impact factor: 4.823

8.  A major binding protein for leukemia inhibitory factor in normal mouse serum: identification as a soluble form of the cellular receptor.

Authors:  M J Layton; B A Cross; D Metcalf; L D Ward; R J Simpson; N A Nicola
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

9.  IL-12 receptor deficiency revisited: IL-23-mediated signaling is also impaired in human genetic IL-12 receptor beta1 deficiency.

Authors:  Marieke A Hoeve; Tjitske de Boer; Dennis M L Langenberg; Ozden Sanal; Frank A W Verreck; Tom H M Ottenhoff
Journal:  Eur J Immunol       Date:  2003-12       Impact factor: 5.532

10.  A human high affinity interleukin-5 receptor (IL5R) is composed of an IL5-specific alpha chain and a beta chain shared with the receptor for GM-CSF.

Authors:  J Tavernier; R Devos; S Cornelis; T Tuypens; J Van der Heyden; W Fiers; G Plaetinck
Journal:  Cell       Date:  1991-09-20       Impact factor: 41.582

View more
  4 in total

Review 1.  IL12Rβ1: the cytokine receptor that we used to know.

Authors:  Richard T Robinson
Journal:  Cytokine       Date:  2014-12-13       Impact factor: 3.861

2.  γ-herpesvirus latency attenuates Mycobacterium tuberculosis infection in mice.

Authors:  Halli E Miller; Kaitlin E Johnson; Vera L Tarakanova; Richard T Robinson
Journal:  Tuberculosis (Edinb)       Date:  2019-04-30       Impact factor: 3.131

Review 3.  The Many Hosts of Mycobacteria 8 (MHM8): A conference report.

Authors:  Michelle H Larsen; Karen Lacourciere; Tina M Parker; Alison Kraigsley; Jacqueline M Achkar; Linda B Adams; Kathryn M Dupnik; Luanne Hall-Stoodley; Travis Hartman; Carly Kanipe; Sherry L Kurtz; Michele A Miller; Liliana C M Salvador; John S Spencer; Richard T Robinson
Journal:  Tuberculosis (Edinb)       Date:  2020-02-11       Impact factor: 3.131

4.  Human IL12RB1 expression is allele-biased and produces a novel IL12 response regulator.

Authors:  Allison E Reeme; Tiffany A Claeys; Praful Aggarwal; Amy J Turner; John M Routes; Ulrich Broeckel; Richard T Robinson
Journal:  Genes Immun       Date:  2018-03-30       Impact factor: 2.676

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.